103 related articles for article (PubMed ID: 11109540)
1. Teratologic studies on rat perinates and offspring from dams treated with ethylnitrosourea (ENU).
Katayama K; Ishigami N; Suzuki M; Ohtsuka R; Kiatipattanasakul W; Nakayama H; Doi K
Exp Anim; 2000 Jul; 49(3):181-7. PubMed ID: 11109540
[TBL] [Abstract][Full Text] [Related]
2. Ethylnitrosourea induces apoptosis and growth arrest in the trophoblastic cells of rat placenta.
Katayama K; Ueno M; Takai H; Ejiri N; Uetsuka K; Nakayama H; Doi K
Biol Reprod; 2002 Aug; 67(2):431-5. PubMed ID: 12135877
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic cell death and cell proliferative activity in the rat fetal central nervous system from dams administered with ethylnitrosourea (ENU).
Katayama K; Uetsuka K; Ishigami N; Nakayama H; Doi K
Histol Histopathol; 2001 Jan; 16(1):79-85. PubMed ID: 11193215
[TBL] [Abstract][Full Text] [Related]
4. Ethylnitrosourea (ENU)-induced apoptosis in the rat fetal tissues.
Katayama K; Ishigami N; Uetsuka K; Nakayama H; Doi K
Histol Histopathol; 2000 Jul; 15(3):707-11. PubMed ID: 10963114
[TBL] [Abstract][Full Text] [Related]
5. Ethylnitrosourea-induced apoptosis in primordial germ cells of the rat fetus.
Katayama K; Ueno M; Yamauchi H; Nakayama H; Doi K
Exp Toxicol Pathol; 2002 Nov; 54(3):193-6. PubMed ID: 12484555
[TBL] [Abstract][Full Text] [Related]
6. Testicular development and fertility of mice treated prenatally with N-nitroso-N-ethylurea at various gestational stages.
Nagao T; Sato M; Marumo H; Shibuya T; Imai K
Teratog Carcinog Mutagen; 1996; 16(3):183-98. PubMed ID: 8983120
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous and nitrosourea-induced primary tumors of the central nervous system in Fischer 344 rats exposed to frequency-modulated microwave fields.
Adey WR; Byus CV; Cain CD; Higgins RJ; Jones RA; Kean CJ; Kuster N; MacMurray A; Stagg RB; Zimmerman G
Cancer Res; 2000 Apr; 60(7):1857-63. PubMed ID: 10766172
[TBL] [Abstract][Full Text] [Related]
8. Effects of prenatal hydroxyurea-treatment on mouse offspring.
Woo GH; Katayama K; Bak EJ; Ueno M; Yamauchi H; Uetsuka K; Nakayama H; Doi K
Exp Toxicol Pathol; 2004 Oct; 56(1-2):1-7. PubMed ID: 15581269
[TBL] [Abstract][Full Text] [Related]
9. Expression of p53 and its transcriptional target genes mRNAs in the ethylnitrosourea-induced apoptosis and cell cycle arrest in the fetal central nervous system.
Katayama K; Ohtsuka R; Takai H; Nakayama H; Doi K
Histol Histopathol; 2002; 17(3):715-20. PubMed ID: 12168779
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the potential promoting effect of 60 Hz magnetic fields on N-ethyl-N-nitrosourea induced neurogenic tumors in female F344 rats.
Mandeville R; Franco E; Sidrac-Ghali S; Paris-Nadon L; Rocheleau N; Mercier G; Désy M; Devaux C; Gaboury L
Bioelectromagnetics; 2000 Feb; 21(2):84-93. PubMed ID: 10653618
[TBL] [Abstract][Full Text] [Related]
11. Congenital malformations in the offspring of male mice treated with ethylnitrosourea at the embryonic stage.
Wada A; Sato M; Takashima H; Nagao T
Teratog Carcinog Mutagen; 1994; 14(6):271-9. PubMed ID: 7709364
[TBL] [Abstract][Full Text] [Related]
12. Reproductive toxicity evaluation of a new camptothecin anticancer agent, CKD-602, in pregnant/lactating female rats and their offspring.
Chung MK; Kim CY; Kim JC
Cancer Chemother Pharmacol; 2007 Feb; 59(3):383-95. PubMed ID: 16896929
[TBL] [Abstract][Full Text] [Related]
13. Teratogenic effect of extended administration of N-nitrosoethylurea and ethylurea/nitrite in rats.
Dreosti IE; McMichael AJ; Bridle TM
Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):265-81. PubMed ID: 6635320
[TBL] [Abstract][Full Text] [Related]
14. Microarray analysis of genes in fetal central nervous system after ethylnitrosourea administration.
Katayama K; Ueno M; Yamauchi H; Nakayama H; Doi K
Birth Defects Res B Dev Reprod Toxicol; 2005 Jun; 74(3):255-60. PubMed ID: 15954086
[TBL] [Abstract][Full Text] [Related]
15. Craniofacial malformations induced by N-ethyl-N-nitrosourea in rat embryos in vivo and in vitro.
Ohnishi M
Kobe J Med Sci; 1989 Apr; 35(2):47-63. PubMed ID: 2796261
[TBL] [Abstract][Full Text] [Related]
16. The relationship between fetal growth restriction and small placenta in 6-mercaptopurine exposed rat.
Furukawa S; Hayashi S; Usuda K; Abe M; Ogawa I
Exp Toxicol Pathol; 2011 Jan; 63(1-2):89-95. PubMed ID: 19926270
[TBL] [Abstract][Full Text] [Related]
17. Male-mediated teratogenesis: spectrum of congenital malformations in the offspring of A/J male mice treated with ethylnitrosourea.
Nagao T; Fujikawa K
Teratog Carcinog Mutagen; 1996; 16(6):301-5. PubMed ID: 9178452
[TBL] [Abstract][Full Text] [Related]
18. Phenobarbital lacks promoting activity for neurogenic tumors in F344 rats transplacentally exposed to ethylnitrosourea.
Walker VE; Swenberg JA
J Neuropathol Exp Neurol; 1989 May; 48(3):263-9. PubMed ID: 2703856
[TBL] [Abstract][Full Text] [Related]
19. Congenital malformations of the central nervous system and transplacental carcinogenesis: modification of ethylnitrosourea-induced brain tumors in rats by pretreatment with methylazoxymethanol.
Kalter H; Ormsby I; Warkany J
Int J Biol Res Pregnancy; 1982; 3(3):93-8. PubMed ID: 7174145
[TBL] [Abstract][Full Text] [Related]
20. Correlations between the degree and type of forebrain malformations and the simultaneous neuro-oncogenic properties of ethylnitrosourea after diaplacental exposure in rats, alone and in combination with X-irradiation.
Schmahl W; Kriegel H
Teratog Carcinog Mutagen; 1985; 5(3):159-75. PubMed ID: 2866600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
